# Amazentis SA clinical trials: 33 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 33 trials with Amazentis SA as lead sponsor, 4 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Amazentis SA: 33 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/amazentis-sa

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 33
- Recruiting or not yet: 4
- Read on: November 19, 2026

## Trials

The 25 newest of 33, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07925853 | Bioavailability of Two Mitopure Formulations | Amazentis SA | Not applicable | Not yet recruiting | Healthy Adults | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925853) |
| August 3, 2026 | NCT07740824 | A Double-Blind, Randomized, Double-Dummy, Active and Placebo-Controlled Clinical Study to Assess the Effect of an Oral Skin Supplement on... | Amazentis SA | Not applicable | Recruiting | Skin Aging | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07740824) |
| April 8, 2026 | NCT07517913 | Cerebrospinal Fluid Kinetics of Urolithin A | Amazentis SA | Not applicable | Completed | Healthy Adult | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07517913) |
| April 8, 2026 | NCT07517900 | Human Skin Safety Testing of 1 Mitopure Topical Product Using a Clinical Safety in Use Study in Healthy Volunteers | Amazentis SA | Not applicable | Completed | Healthy Adult | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07517900) |
| April 8, 2026 | NCT07517887 | Anti-aging Efficacy Study on One Cosmetic Product Containing Mitopure | Amazentis SA | Not applicable | Completed | Aging, Wrinkle Appearance | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07517887) |
| April 8, 2026 | NCT07517874 | Human Skin Safety Testing of 1 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers | Amazentis SA | Not applicable | Completed | Irritation/Irritant, Sensitisation | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07517874) |
| November 17, 2025 | NCT07231848 | Bioavailability of Four Mitopure Formulations | Amazentis SA | Not applicable | Completed | Healthy Adults | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07231848) |
| November 17, 2025 | NCT07231783 | The Effect of Urolithin A (Mitopure®) Supplementation on Muscle Strength in Healthy Middle-Aged Adults | Amazentis SA | Not applicable | Recruiting | Healthy Aging, Muscle Function | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07231783) |
| August 12, 2025 | NCT07118943 | Efficacy of Four Topical Products to Improve Skin Longevity | Amazentis SA | Not applicable | Completed | Aging, Wrinkle | 132 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07118943) |
| August 3, 2025 | NCT07100912 | Human Skin Safety Testing of 6 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers | Amazentis SA | Not applicable | Completed | Irritation/Irritant, Sensitisation | 113 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07100912) |
| July 31, 2025 | NCT07096466 | Skin Cell Regeneration Efficacy of Cosmetic Product | Amazentis SA | Not applicable | Completed | Healthy Skin | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07096466) |
| July 11, 2025 | NCT07060898 | Impact of a Novel Brain Longevity Supplement Containing the Postbiotic Urolithin A (Mitopure) on Cognitive Function and Related Health... | Amazentis SA | Not applicable | Active not recruiting | Aging, Cognitive Decline, Brain Fog, Cognitive Function | 650 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07060898) |
| May 4, 2025 | NCT06956625 | Cleansing Efficacy of Cosmetic Product | Amazentis SA | Not applicable | Completed | Healthy Skin | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06956625) |
| April 17, 2025 | NCT06932770 | Anti-aging Efficacy of Food Supplement and Cosmetic Routine | Amazentis SA | Not applicable | Completed | Aging, Wrinkle | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06932770) |
| March 19, 2025 | NCT06884215 | Human Skin Safety Testing of Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers | Amazentis SA | Not applicable | Completed | Irritation/Irritant, Sensitisation | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06884215) |
| February 28, 2025 | NCT06853197 | Bioavailability of Seven Mitopure Formulations | Amazentis SA | Not applicable | Completed | Healthy Adults | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06853197) |
| October 1, 2024 | NCT06619457 | Evaluation of the Anti-aging Efficacy of One Face Care Cosmetic Product | Amazentis SA | Not applicable | Completed | Skin Aging | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06619457) |
| August 16, 2024 | NCT06556706 | Impact of Urolithin A (Mitopure) on Mitochondrial Quality in Muscle of Frail Older Adults | Amazentis SA | Not applicable | Completed | Frailty, Sarcopenia, Aging, Muscle Atrophy | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06556706) |
| April 12, 2024 | NCT06362018 | Bioavailability of Five Mitopure Formulations | Amazentis SA | Not applicable | Completed | Healthy Adults | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06362018) |
| April 10, 2023 | NCT05805735 | Anti-Wrinkle Efficacy Study of an Eye-Cream | Amazentis SA | Not applicable | Completed | Aging, Wrinkle | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05805735) |
| February 21, 2023 | NCT05735886 | Urolithin A Supplementation to Boost Immune Health | Amazentis SA | Not applicable | Completed | Aging | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05735886) |
| July 26, 2022 | NCT05473832 | Evaluation of the Anti-aging Efficacy of Four Skin Health Products | Amazentis SA | Not applicable | Completed | Anti-Aging, Skin Aging | 144 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05473832) |
| March 29, 2022 | NCT05300984 | Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product | Amazentis SA | Not applicable | Completed | Skin Aging | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05300984) |
| March 29, 2022 | NCT05300542 | Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema | Amazentis SA | Not applicable | Completed | Erythema, Sun Damaged Skin, Skin Inflammation | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05300542) |
| October 15, 2021 | NCT05079607 | Human Skin Safety Testing of a Mitopure Topical Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers | Amazentis SA | Not applicable | Completed | Irritation/Irritant, Sensitisation | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05079607) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 1 |
| Not applicable | 31 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 28 |
| Recruiting | 3 |
| Active not recruiting | 1 |
| Not yet recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Frailty | 2 |
| Mitochondrial Diseases | 1 |
| Cognitive Dysfunction | 1 |
| Mental Fatigue | 1 |
| Erythema | 1 |
| Dermatitis | 1 |
| Sarcopenia | 1 |
| Muscular Atrophy | 1 |
| Overweight | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Italian restaurants in the United States](https://specstream.ai/data/businesses/italian-restaurants/united-states)
- [Endocrinology practices in the United States](https://specstream.ai/data/businesses/endocrinology-practices/united-states)
- [Bistros in the United States](https://specstream.ai/data/businesses/bistros/united-states)
- [Urology practices in the United States](https://specstream.ai/data/businesses/urology-practices/united-states)
- [Private jet charter companies in the United States](https://specstream.ai/data/businesses/private-jet-charter-companies/united-states)
- [Landscape architecture firms in the United States](https://specstream.ai/data/businesses/landscape-architecture-firms/united-states)
